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Although the back school is a popular treatment for
patients with low back pain, especially in Scandina-
vian countries, very few well-designed studies into
the effectiveness of this type of treatment have been
performed. Back schools are programs in a group
setting, directed toward pain management and con-
sisting of elements of education and/or training of
skills. The Maastricht Back School is designed to be
a combination of all those elements about which we
consider a back school should give information and
training. In order to determine the effectiveness of the
Maastricht Back School, we conducted a randomized
trial (n = 77) comparing a group that attended back
school with a waiting list control group. The most
important measures of effect were pain management,
pain, medical consumption, and absenteeism from
work. The overall response was 85.5%. The results of
an intention-to-treat analysis of the data collected 2
and 6 months after randomization consistently sug-
gested inefficacy of the Maastricht Back School for
all effect parameters (except for the effect parameter
knowledge). Though the present study certainly had
some limitations, we question the clinical relevancy
of back schools.
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One of the possible treatments for patients suffering
from low back pain is the so-called back school,
which is of Swedish origin [1, 2]. Back schools offer
an education and skills program in a group setting
(10 to 12 patients per group) and primarily are aimed
at pain management: information is given about ways
of dealing with pain, so that the patient is able to
control his or her pain problem more effectively [3].
Although the back school is a popular treatment for
patients suffering from low back pain, the results of
the few well-designed studies into the effectiveness
of this treatment indicate, at most, borderline effects
for the back school [4].
The Maastricht Back School consists of seven ses-
sions, each lasting 2.5 hours, plus a refresher session
after 6 months. A course instructor is present at every
session. In addition, various guest lecturers are in-
vited to give information and training. The Maas-
tricht Back School approaches pain in a multidimen-
sional way, which is generally accepted to be a
desirable method [4]. This school is designed to be a
combination of all elements about which we consider
a back school should give information and/or train-
ing. In order to investigate the effectiveness of the
Maastricht Back School, we conducted a randomized
trial in primary health care, comparing a group re-
ceiving the Maastricht Back School treatment with a
waiting list control group. Patients in the waiting list
control group were promised back school treatment
at the end of the study. If the Maastricht Back School
turns out to be effective, it will be implemented in
Dutch outpatient care. This implies that up till now,
the Maastricht Back School does not form a part of the
primary health care system and that it was initially
developed for the research project.
After presenting the inclusion and exclusion crite-
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ria and the effect parameters, this article describes
the methods of data analysis. Next, the principal re-
sults of the evaluation study are presented. Finally,
results and validity of the study are discussed.
MATERIALS AND METHODS
Selection of Patients
The inclusion criteria for the study required the pres-
ence of low back pain for at least 2 months, with a
maximum of 3 years. Patients eligible for medical and
surgical treatment were excluded, as were those who
were unable to participate in a physical exercise pro-
gram and a relaxation training (since these are essen-
tial parts of the Maastricht Back School). Prospective
participants were judged on all these criteria by the
general practitioners recruiting the study population.
Effect Parameters
The most important effect parameters in this study
were (1) pain management; (2) pain, measured by (a)
the West Haven—Yale Multidimensional Pain Inven-
tory (WHYMPI), subdivided into influence of pain
on daily life, reactions from the environment, and
activities 15) and (b) a visual analogue scale (VAS)
[6]; (3) medical consumption, subdivided into con-
sultations with health care providers, treatments, and
medicine taking; and (4) absenteeism from work. Pain
and pain management were both measured by a VAS.
For pain, the anchor words were "no pain" and
"much pain"; for pain management, they were "not
able to manage the pain" and "very much able to
manage the pain." The number of consultations with
health care providers was determined by adding the
frequencies of consultations with a general prac-
titioner, a physical or manual therapist, a specialist,
or some alternative physician. The number of treat-
ments were determined by adding the number of
common methods of treatments for patients with low
back pain. Medicine taking was computed by adding
the number of types of medicine usually prescribed
for low back pain. Absenteeism from work was ex-
pressed in number of days. Other outcome measures
were functional restrictions (measured by the Sick-
ness Impact Profile [7]), knowledge of the Course
Content, general well-being, and satisfaction. General
well-being as well as satisfaction with the Maastricht
Back School were measured by a VAS. For general
well-being, the anchor words were "feeling very bad"
and "feeling very well"; for satisfaction with the
course. they were "very dissatisfied" and "very sat-
isfied."
Data on all of these parameters were collected at
TABLE 1
Data Collection Schedule
2	 6
Instrument	 Baseline	 Months	 Months
Pain management 	 X
	
X
Pain (WHYNIPI)	 X	 X
Pain (VAS)	 X	 X
Medical consumption	 X
Work absenteeism	 X
Functional
	
X
restrictions (SIP)
Knowledge	 X
General well-being	 X
	
X
Satisfaction	 X
WHYMPI. West Haven—Yale Multidimensional Pain Inventory; VAS, vi-
sual analogue scale: and SIP, Sickness Impact Profile.
baseline, and 2 and 6 months after assignment to
treatment or control groups. All information was
gathered by way of questionnaires and filled out by
the patients. Table 1 shows the schedule of data col-
lection.
Methods
In order to examine the effect of the Maastricht Back
School, we performed univariate anal yses of variance
(ANovAs) and, if there was more than one dependent
variable, multivariate analyses of variance (mANovAs)
of the repeated measures data (also called mixed be-
tween-within-subjects MANOVA, split plot, or ran-
domized block factorial design), using the SPSS-X
package [8]. The independent variables were "condi-
tion," with two levels (experimental and control
group), and "time," with three levels (baseline, 2
months after randomization, and 6 months after ran-
domization). The ANOVA and MANOVA repeated-mea-
sures techniques provided a general test of whether
groups with and without Maastricht Back School
treatment differed over time for the effect parameter
at issue. In other words, the ANOVA and MANOVA re-
peated measures tested (1) the difference between the
two treatment groups without considering levels of
time (effect of condition): (2) the difference in time
without considering levels of condition (effect of
time); and (3) the difference across time beween the
two treatment groups (effect of interaction, that is,
the effect of condition x time). If the effect of interac-
tion is significant, this indicates that one type of treat-
ment (Maastricht back school or waiting list control)
"works best." Hence, the effect of interaction gives us
information about the main research question, which
was: Is there a difference in effect between a group
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receiving back school treatment and a waiting list
control group? An alternative to ANOVA of the re-
peated measures data would have been a separate
analysis for each moment of data collection and for
each dependent variable. However, due to the num-
ber of effect parameters, this would lead to an exces-
sive number of significance tests and, thus, to chance
capitalizing. The results of an evaluation of the main
assumptions of ANOVA and MANOVA [8] were satis-
factory.
Furthermore, univariate analyses of covariance
(ANcovAs) and multivariate analyses of covariance
(MANCOVAS) of the repeated measures data were per-
formed on most of the dependent variables, in order
to determine the effectiveness of the Maastricht Back
School after adjustment for differences between the
groups in baseline scores, pain duration, cause of the
pain, sex, level of education, and age. These covari-
ates were used because they were found to correlate
strongly with most dependent variables (Pearson cor-
relation coefficients). If in an ANCOVA or MANCOVA
the effect of interaction is significant, this indicates
that after adjustment for the covariate (such as base-
line scores) one type of treatment "works best." The
results of an evaluation of the main assumptions of
ANCOVA and MANCOVA [8] were satisfactory.
RESULTS
Of the 96 patients who applied for the Maastricht
Back School, six were not willing to sign the informed
consent. Of the remaining 90 patients, 13 dropped
out (defined as not filling out the questionnaires at
all three moments of data collection); six patients
were of the experimental group and seven of the wait-
ing list control group. The main reasons for not com-
pleting the trial were of a practical (for example, an
operation on a patient's knee) or private nature (for
instance, illness of a family member). Six of the 13
dropouts were lost at the first moment of data collec-
tion. Therefore, no baseline data were available for
these six dropouts. The remaining seven patients
dropped out at either the second or third moment of
data collection. The mean age of these seven patients,
who were all men, was 42.1 years, and they had an
average pain duration of 9.8 years.
The patients included 39 men and 38 women, with
a mean age of 35.8 years. Although the general prac-
titioners selected on pain duration, we inquired after
patients' pain duration. The average pain duration
was 7.5 years, which is not in accordance with the
inclusion criterion of low back pain for at least 2
months, with a maximum of 3 years. The educational
level of most of the patients was that of vocational
school. Forty-four patients had at the time of the
study a full-time or part-time job. Due to their back
pain, 14 patients received a state disability benefit.
Compared to the waiting list control group, the exper-
imental group included more women (14 in the ex-
perimental group and 24 in the waiting list control
group) and more patients receiving a state disability
benefit (11 in the experimental group, and three in
the waiting list control group). Furthermore, the edu-
cational level in the experimental group was lower.
For all other demographic variables, no meaningful
differences between the experimental and waiting
list control group were found. As shown by the means
presented in Table 2, at baseline both groups differed
substantially on almost all effect parameters used.
In order to explain in detail the procedure of data
analysis, the effect of the Maastricht Back School on
medicine taking (a subdivision of the medical con-
sumption) is presented by way of example. Data on
other effect parameters were analyzed in exactly the
same way. Because the findings were consistent, they
are not discussed in detail for all other effect parame-
ters. Patients were asked about their medicine taking
at baseline and 6 months after randomization. They
were asked what medication they had been using for
their back pain during the last 6 months. Medicine
taking per patient was then calculated by counting
the types of medicine (for example, tranquilizers)
they used. The maximum number of types was seven.
If a patient used all types of medicine, the score was
7; if a patient used none of them, the score was 0.
Step one of the general procedure followed consisted
of an analysis of the calculated means. The means of
each data collection for the experimental group and
the waiting list control group are presented graphi-
cally in Figure 1.
Given the random procedure, it is somewhat sur-
prising that the means for the experimental and the
waiting list control groups already differed substan-
tially at baseline (a t test between the groups showed
that this difference was statistically significant at P
= 0.031). Six months after randomization, the means
for the two groups still differed substantially. The
next step, which was the most interesting one with
regard to the central question of the study, was to find
out whether the change in the experimental group
was larger than that in the waiting list control group.
This effect of interaction turned out not to be statisti-
cally significant (df = 1.75; F = .079; P = .779);
however, the effects of time (df = 1.75; F = 14.68;
P = .001) and condition (df = 1.75; F = 11.84; P =
.001) were significant. This indicates that with regard
to medicine taking, there was no difference between
Arthritis Care and Research
	 Efficacy of Back School: Randomized Trial 207
TABLE 2
Means of the Experimental and Control Groups for Each Effect Parameter and Data Collectiona
Condition
Experimental Control
Baseline 2 Months 6 Months Baseline 2 Months 6 Months
Pain management (range, 1-10) 4.79 (1.86) 5.88 (1.97) 5.82 (2.05) 5.43 (1.93) 5.65 (1.96) 6.25 (1.85)
Pain (WHYMPI)
Influence of pain on daily life
(range, 0-6)
3.53 (1.23) 3.38 (1.25) 3.14 (1.39) 3.25 (1.30) 3.10 (1.28) 2.86 (1.32)
Reactions from the
environment (range, 0-6)
2.47 (1.14) 2.26 (1.08) 2.19 (1.10) 2.13 (1.15) 1.94 (1.11) 2.11 (1.23)
Activities (range, 0-6) 2.96 (1.33) 2.91 (1.31) 2.84 (1.30) 3.00 (1.39) 2.97 (1.32) 3.11 (1.45)
Pain (VAS) (range, 1-10) 6.49 (2.33) 5.35 (2.38) 5.35 (2.84) 5.77 (2.74) 5.15 (2.65) 4.10 (2.75)
Medical consumption
Consultations (range, 23.27 (22.38) 9.00 (10.99) 16.08 (15.31) 6.63 (9.04)
Treatments (range, 0-22) 3.27 (2.66) 1.84 (2.03) 2.63 (2.05) 1.00 (1.22)
Medicine taking (range, 0-7) 1.22 (0.98) 0.81 (1.08) 0.63 (0.70) .28 (0.51)
Work absenteeism (range, 0-x) 27.00 (43.28) 19.00 (43.18) 21.26 (25.44) 3.43 (10.16)
Functional restrictions (SIP)
Physical impairment
(range, 0-3)
0.17 (0.28) 0.12 (.20) 0.05 (0.09) 0.04 (0.06)
Psychosocial impairment
(range, 0-4)
0.42 (0.58) 0.38 (.51) 0.14 (0.23) 0.14 (0.22)
Knowledge (range, 0-25) 18.78 (4.26) 17.62 (4.53) 14.20 (4.30) 13.70 (4.88)
General well-being (range, 1-10) 5.18 (2.33) 5.65 (2.44) 5.82 (2.47) 5.85 (2.24) 6.08 (2.32) 7.13 (2.40)
WHYMPI, West Haven-Yale Multidimensional Pain Inventory; VAS, visual analogue scale; and SIP, Sickness Impact Profile.
For all ranges except "pain management," "activities," "knowledge." and "general well-being" the higher the figure given, the worse was the score on that
relevant effect parameter. All data are means and standard deviations.
2
0
	
pretest	 follow-up
Figure 1. Means for data on medicine-taking at baseline and 6 months after randomization (sum of types; range, 0-7):
	 , experimental; and 	 , control.
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TABLE 3
Test Statistics from MANOVA Repeated Measures for the
Interaction Effects Condition x Time for the Effect
Parameters
Effect parameters F df P value
Pain management 2.21 2,71 .12
Pain (WHYMPI) .91 12.64 .59
Pain (VAS) 1.32 2,73 .27
Medical consumption
Consultations .36 5.58 .87
Treatments 1.32 16,60 .22
Medicine taking .08 1,75 .78
Work absenteeism .56 1,42 .46
Functional restrictions (SIP) 1.33 2.74 --.27
General well-being 1.05 2,70 .36
kVIIYNIPI, West I laven-Yale Multidimensional Pain Inventory; VAS, vi-
sual analogue scale; and SIP, Sickness Impact Profile.
the back school treatment and waiting list control
groups. Looking again at Figure 1, it can be seen that
the two groups differed over time (the effect of time)
and that the means for the experimental group dif-
fered from those for the waiting list control group
(the effect of condition). With regard to medicine
taking, the gain for the experimental group was not
larger than the gain for the waiting list control group
(effect of interaction).
This same procedure was carried out for all effect
parameters. Because the results were in general simi-
lar for all measures of effect, they are not discussed
in detail. Instead the effects of interaction for the
effect parameters are presented, because these are
the most interesting ones with regard to the research
question. Table 3 summarizes these effects of interac-
tion. It shows that there are no significant effects of
interaction. In Table 2, the corresponding means for
the experimental and control groups are given for
each data collection and effect parameter.
ANCOVAS and MANCOVAS for the repeated measures
data did not reveal significant effects of interaction
either. Nor did subgroup analyses based on several
prognostic variables (sex, pain duration, age, and
level of education) show statistically significant ef-
fects of interaction.
Summarizing the results, it can be said for all effect
parameters that:
1. Both the experimental group and the waiting list
control group showed progress with time (signifi-
cant effects of time). However, the experimental
group did not show significantly more progress
(effects of interactions were not significant).
Although patients were randomly assigned to
treatment groups, there were substantial differ-
ences in some prognostic variables (for example,
sex).
After adjustment for these differences, there was
still no difference in effect between the group re-
ceiving back school treatment and the waiting list
control group.
DISCUSSION
The present study failed to reject the null hypothesis
stating that there is no difference in effect between a
group receiving back school treatment and a waiting
list control group. Besides the apparent inefficacy of
the Maastricht Back School, some problems concern-
ing the validity of the study need to be discussed.
1. The number of patients in the study was relatively
small [77] and, therefore, only relatively large ef-
fects could be detected (lack of power of the study)
[9].
2. Internationally acknowledged reliable and valid
effect parameters with regard to (low back) pain
are scarce. Moreover, the available reliable and
valid effect parameters might be insensitive to
changes with time. For the Sickness Impact Pro-
file, for example, interim surveys have shown sat-
isfying results regarding its reliability and validity
[7]. On the other hand, the Sickness Impact Profile
may have been insensitive to changes with time
[10].
The differences at baseline may be due to data
collection after randomization instead of before.
Filling out questionnaires knowing whether one
can start with the back school might bias one's
answers.
It might be argued that the differences in baseline
scores were responsible for the nonexistence of
the expected significant effects of interaction. We
do not think, however, that this is the case. More
serious patients, who seem to be more prevalent
in the experimental group, might have been ex-
pected to profit more from the treatment than the
less serious patients in the control group. That is
to say that the differences at baseline might in this
case be expected to enhance the probability of
finding significant effects of interaction.
5. Back pain complaints often fluctuate with time.
Patients who sign up for a back school probably
have serious complaints at that time and thus
score extremely high, so that scores 2 and 6
months after randomization tend to be lower, due
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to fluctuations that are intrinsic to the natural his-
tory of back pain. This implies that it will be diffi-
cult to show effects of the Maastricht Back School,
which are small compared to these fluctuations
with time. On the other hand, it can be argued that
such small effects lack clinical relevance anyhow.
6. A waiting list control group is not entirely compa-
rable to a control group receiving a different or
placebo intervention. In a waiting list control
group, the knowledge that one will enter the de-
sired back school treatment within half a year
might already have some therapeutic effect. An-
other possibility is that patients on a waiting list
may seek some alternative treatment white wait-
ing, or already start behaving in accordance with
the ideas of the back school.
Although bias cannot be excluded from our study
results, it does not seem very likely that the Maas-
tricht Back School is an effective method of managing
low back pain. Furthermore, due to the required mul-
tidimensional approach of pain in the Maastricht
Back School, the results of this study further reduce
the likelihood of any back school in its present setup
being effective. The limited evidence available from
other randomized trials indicates, at most, borderline
effects for other back schools [3, 4]. Very large trials
with perfect methodology, avoiding the shortcom-
ings of our own and other studies, might yet show
some beneficial effects, although we do not think
such trials deserve high priority.
This study was supported by a grant from the Dutch Prevention
Foundation.
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